Friday, December 30, 2016

Best practices to fund, develop and commercialize evidence-based mental health innovation

{ http://ift.tt/2ilMUft

In this session we discuss key lessons learned for scientists and start-ups to successfully bring to market evidence-based innovative solutions. We will present non-dilutive funding opportunities and commercialization resources offered through the US small business research programs, and a scientist and inventor turned serial entrepreneur wrap-ups the day sharing insights from his previous venture–funded by the NIMH and sold to McKesson–and his current strategy and vision.

  • Chair: Dr. Alison Fenney, Executive Director of the Neurotechnology Industry Organization
  • Dr. Margaret Grabb, SBIR/STTR Program Director at the National Institute of Mental Health (NIMH)
  • Dr. Rex Jakobovits, Founder of Vivalog Technologies and Experiad

These presentations took place at the 2016 SharpBrains Virtual Summit: Reinventing Brain Health in the Digital Age (December 6-8th, 2016).



{ All Hypnosis Feeds

via SharpBrains http://sharpbrains.com

December 30, 2016 at 05:26AM

No comments:

Post a Comment